The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Coronary Drug-Coated Balloon Market Research Report 2025
Synopsis
The DEB may become a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularisation, as it allows local release of a high-concentration antirestenotic drug, paclitaxel, into the coronary vessel without using a metal scaffold or durable polymers.
The global Coronary Drug-Coated Balloon market was valued at US$ 441.3 million in 2023 and is anticipated to reach US$ 1229.4 million by 2030, witnessing a CAGR of 15.8% during the forecast period 2024-2030.
The Coronary Drug-Coated Balloon market is driven by the need for improved treatment options for coronary artery disease (CAD). These specialized balloons are designed to deliver drugs directly to the site of arterial blockages during angioplasty, preventing restenosis and promoting vessel healing. The rise in CAD cases and the demand for minimally invasive interventions contribute to market growth as patients and cardiologists seek solutions that reduce the need for repeat procedures. Moreover, advancements in drug formulation and balloon technology, including controlled drug release and enhanced drug adherence, align with better patient outcomes. However, the market also faces challenges, including addressing the potential for adverse reactions to the drug coating and ensuring precise drug delivery to the targeted area. Additionally, navigating regulatory approvals and conducting long-term efficacy studies can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and effective drug-coated balloon solutions, collaborate with interventional cardiologists for insights, and address the challenges to meet the increasing demand for advanced CAD treatment options.
This report aims to provide a comprehensive presentation of the global market for Coronary Drug-Coated Balloon, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coronary Drug-Coated Balloon.
Report Scope
The Coronary Drug-Coated Balloon market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Coronary Drug-Coated Balloon market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Coronary Drug-Coated Balloon manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
B. Braun
Yinyi
Eurocor
Biotronic
Segment by Type
Paclitaxel Coated
Other Coated
Segment by Application
Hospitals
ASCs
Catheterization Laboratory
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Coronary Drug-Coated Balloon manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Coronary Drug-Coated Balloon in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The DEB may become a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularisation, as it allows local release of a high-concentration antirestenotic drug, paclitaxel, into the coronary vessel without using a metal scaffold or durable polymers.
The global Coronary Drug-Coated Balloon market was valued at US$ 441.3 million in 2023 and is anticipated to reach US$ 1229.4 million by 2030, witnessing a CAGR of 15.8% during the forecast period 2024-2030.
The Coronary Drug-Coated Balloon market is driven by the need for improved treatment options for coronary artery disease (CAD). These specialized balloons are designed to deliver drugs directly to the site of arterial blockages during angioplasty, preventing restenosis and promoting vessel healing. The rise in CAD cases and the demand for minimally invasive interventions contribute to market growth as patients and cardiologists seek solutions that reduce the need for repeat procedures. Moreover, advancements in drug formulation and balloon technology, including controlled drug release and enhanced drug adherence, align with better patient outcomes. However, the market also faces challenges, including addressing the potential for adverse reactions to the drug coating and ensuring precise drug delivery to the targeted area. Additionally, navigating regulatory approvals and conducting long-term efficacy studies can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and effective drug-coated balloon solutions, collaborate with interventional cardiologists for insights, and address the challenges to meet the increasing demand for advanced CAD treatment options.
This report aims to provide a comprehensive presentation of the global market for Coronary Drug-Coated Balloon, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Coronary Drug-Coated Balloon.
Report Scope
The Coronary Drug-Coated Balloon market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Coronary Drug-Coated Balloon market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Coronary Drug-Coated Balloon manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
B. Braun
Yinyi
Eurocor
Biotronic
Segment by Type
Paclitaxel Coated
Other Coated
Segment by Application
Hospitals
ASCs
Catheterization Laboratory
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Coronary Drug-Coated Balloon manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Coronary Drug-Coated Balloon in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Coronary Drug-Coated Balloon Market Overview
1.1 Product Overview and Scope of Coronary Drug-Coated Balloon
1.2 Coronary Drug-Coated Balloon Segment by Type
1.2.1 Global Coronary Drug-Coated Balloon Market Value Comparison by Type (2024-2030)
1.2.2 Paclitaxel Coated
1.2.3 Other Coated
1.3 Coronary Drug-Coated Balloon Segment by Application
1.3.1 Global Coronary Drug-Coated Balloon Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 ASCs
1.3.4 Catheterization Laboratory
1.4 Global Coronary Drug-Coated Balloon Market Size Estimates and Forecasts
1.4.1 Global Coronary Drug-Coated Balloon Revenue 2019-2030
1.4.2 Global Coronary Drug-Coated Balloon Sales 2019-2030
1.4.3 Global Coronary Drug-Coated Balloon Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Coronary Drug-Coated Balloon Market Competition by Manufacturers
2.1 Global Coronary Drug-Coated Balloon Sales Market Share by Manufacturers (2019-2024)
2.2 Global Coronary Drug-Coated Balloon Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Coronary Drug-Coated Balloon Average Price by Manufacturers (2019-2024)
2.4 Global Coronary Drug-Coated Balloon Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Coronary Drug-Coated Balloon, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Coronary Drug-Coated Balloon, Product Type & Application
2.7 Coronary Drug-Coated Balloon Market Competitive Situation and Trends
2.7.1 Coronary Drug-Coated Balloon Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Coronary Drug-Coated Balloon Players Market Share by Revenue
2.7.3 Global Coronary Drug-Coated Balloon Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Coronary Drug-Coated Balloon Retrospective Market Scenario by Region
3.1 Global Coronary Drug-Coated Balloon Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Coronary Drug-Coated Balloon Global Coronary Drug-Coated Balloon Sales by Region: 2019-2030
3.2.1 Global Coronary Drug-Coated Balloon Sales by Region: 2019-2024
3.2.2 Global Coronary Drug-Coated Balloon Sales by Region: 2025-2030
3.3 Global Coronary Drug-Coated Balloon Global Coronary Drug-Coated Balloon Revenue by Region: 2019-2030
3.3.1 Global Coronary Drug-Coated Balloon Revenue by Region: 2019-2024
3.3.2 Global Coronary Drug-Coated Balloon Revenue by Region: 2025-2030
3.4 North America Coronary Drug-Coated Balloon Market Facts & Figures by Country
3.4.1 North America Coronary Drug-Coated Balloon Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Coronary Drug-Coated Balloon Sales by Country (2019-2030)
3.4.3 North America Coronary Drug-Coated Balloon Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Coronary Drug-Coated Balloon Market Facts & Figures by Country
3.5.1 Europe Coronary Drug-Coated Balloon Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Coronary Drug-Coated Balloon Sales by Country (2019-2030)
3.5.3 Europe Coronary Drug-Coated Balloon Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Coronary Drug-Coated Balloon Market Facts & Figures by Country
3.6.1 Asia Pacific Coronary Drug-Coated Balloon Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Coronary Drug-Coated Balloon Sales by Country (2019-2030)
3.6.3 Asia Pacific Coronary Drug-Coated Balloon Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Coronary Drug-Coated Balloon Market Facts & Figures by Country
3.7.1 Latin America Coronary Drug-Coated Balloon Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Coronary Drug-Coated Balloon Sales by Country (2019-2030)
3.7.3 Latin America Coronary Drug-Coated Balloon Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Coronary Drug-Coated Balloon Market Facts & Figures by Country
3.8.1 Middle East and Africa Coronary Drug-Coated Balloon Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Coronary Drug-Coated Balloon Sales by Country (2019-2030)
3.8.3 Middle East and Africa Coronary Drug-Coated Balloon Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Coronary Drug-Coated Balloon Sales by Type (2019-2030)
4.1.1 Global Coronary Drug-Coated Balloon Sales by Type (2019-2024)
4.1.2 Global Coronary Drug-Coated Balloon Sales by Type (2025-2030)
4.1.3 Global Coronary Drug-Coated Balloon Sales Market Share by Type (2019-2030)
4.2 Global Coronary Drug-Coated Balloon Revenue by Type (2019-2030)
4.2.1 Global Coronary Drug-Coated Balloon Revenue by Type (2019-2024)
4.2.2 Global Coronary Drug-Coated Balloon Revenue by Type (2025-2030)
4.2.3 Global Coronary Drug-Coated Balloon Revenue Market Share by Type (2019-2030)
4.3 Global Coronary Drug-Coated Balloon Price by Type (2019-2030)
5 Segment by Application
5.1 Global Coronary Drug-Coated Balloon Sales by Application (2019-2030)
5.1.1 Global Coronary Drug-Coated Balloon Sales by Application (2019-2024)
5.1.2 Global Coronary Drug-Coated Balloon Sales by Application (2025-2030)
5.1.3 Global Coronary Drug-Coated Balloon Sales Market Share by Application (2019-2030)
5.2 Global Coronary Drug-Coated Balloon Revenue by Application (2019-2030)
5.2.1 Global Coronary Drug-Coated Balloon Revenue by Application (2019-2024)
5.2.2 Global Coronary Drug-Coated Balloon Revenue by Application (2025-2030)
5.2.3 Global Coronary Drug-Coated Balloon Revenue Market Share by Application (2019-2030)
5.3 Global Coronary Drug-Coated Balloon Price by Application (2019-2030)
6 Key Companies Profiled
6.1 B. Braun
6.1.1 B. Braun Corporation Information
6.1.2 B. Braun Description and Business Overview
6.1.3 B. Braun Coronary Drug-Coated Balloon Sales, Revenue and Gross Margin (2019-2024)
6.1.4 B. Braun Coronary Drug-Coated Balloon Product Portfolio
6.1.5 B. Braun Recent Developments/Updates
6.2 Yinyi
6.2.1 Yinyi Corporation Information
6.2.2 Yinyi Description and Business Overview
6.2.3 Yinyi Coronary Drug-Coated Balloon Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Yinyi Coronary Drug-Coated Balloon Product Portfolio
6.2.5 Yinyi Recent Developments/Updates
6.3 Eurocor
6.3.1 Eurocor Corporation Information
6.3.2 Eurocor Description and Business Overview
6.3.3 Eurocor Coronary Drug-Coated Balloon Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eurocor Coronary Drug-Coated Balloon Product Portfolio
6.3.5 Eurocor Recent Developments/Updates
6.4 Biotronic
6.4.1 Biotronic Corporation Information
6.4.2 Biotronic Description and Business Overview
6.4.3 Biotronic Coronary Drug-Coated Balloon Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biotronic Coronary Drug-Coated Balloon Product Portfolio
6.4.5 Biotronic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Coronary Drug-Coated Balloon Industry Chain Analysis
7.2 Coronary Drug-Coated Balloon Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Coronary Drug-Coated Balloon Production Mode & Process
7.4 Coronary Drug-Coated Balloon Sales and Marketing
7.4.1 Coronary Drug-Coated Balloon Sales Channels
7.4.2 Coronary Drug-Coated Balloon Distributors
7.5 Coronary Drug-Coated Balloon Customers
8 Coronary Drug-Coated Balloon Market Dynamics
8.1 Coronary Drug-Coated Balloon Industry Trends
8.2 Coronary Drug-Coated Balloon Market Drivers
8.3 Coronary Drug-Coated Balloon Market Challenges
8.4 Coronary Drug-Coated Balloon Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Coronary Drug-Coated Balloon Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Coronary Drug-Coated Balloon Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Coronary Drug-Coated Balloon Market Competitive Situation by Manufacturers in 2023
Table 4. Global Coronary Drug-Coated Balloon Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Coronary Drug-Coated Balloon Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Coronary Drug-Coated Balloon Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Coronary Drug-Coated Balloon Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Coronary Drug-Coated Balloon Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Coronary Drug-Coated Balloon, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Coronary Drug-Coated Balloon, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Coronary Drug-Coated Balloon, Product Type & Application
Table 12. Global Key Manufacturers of Coronary Drug-Coated Balloon, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Coronary Drug-Coated Balloon by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coronary Drug-Coated Balloon as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Coronary Drug-Coated Balloon Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Coronary Drug-Coated Balloon Sales by Region (2019-2024) & (K Units)
Table 18. Global Coronary Drug-Coated Balloon Sales Market Share by Region (2019-2024)
Table 19. Global Coronary Drug-Coated Balloon Sales by Region (2025-2030) & (K Units)
Table 20. Global Coronary Drug-Coated Balloon Sales Market Share by Region (2025-2030)
Table 21. Global Coronary Drug-Coated Balloon Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Coronary Drug-Coated Balloon Revenue Market Share by Region (2019-2024)
Table 23. Global Coronary Drug-Coated Balloon Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Coronary Drug-Coated Balloon Revenue Market Share by Region (2025-2030)
Table 25. North America Coronary Drug-Coated Balloon Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Coronary Drug-Coated Balloon Sales by Country (2019-2024) & (K Units)
Table 27. North America Coronary Drug-Coated Balloon Sales by Country (2025-2030) & (K Units)
Table 28. North America Coronary Drug-Coated Balloon Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Coronary Drug-Coated Balloon Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Coronary Drug-Coated Balloon Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Coronary Drug-Coated Balloon Sales by Country (2019-2024) & (K Units)
Table 32. Europe Coronary Drug-Coated Balloon Sales by Country (2025-2030) & (K Units)
Table 33. Europe Coronary Drug-Coated Balloon Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Coronary Drug-Coated Balloon Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Coronary Drug-Coated Balloon Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Coronary Drug-Coated Balloon Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Coronary Drug-Coated Balloon Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Coronary Drug-Coated Balloon Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Coronary Drug-Coated Balloon Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Coronary Drug-Coated Balloon Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Coronary Drug-Coated Balloon Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Coronary Drug-Coated Balloon Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Coronary Drug-Coated Balloon Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Coronary Drug-Coated Balloon Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Coronary Drug-Coated Balloon Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Coronary Drug-Coated Balloon Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Coronary Drug-Coated Balloon Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Coronary Drug-Coated Balloon Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Coronary Drug-Coated Balloon Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Coronary Drug-Coated Balloon Sales (K Units) by Type (2019-2024)
Table 51. Global Coronary Drug-Coated Balloon Sales (K Units) by Type (2025-2030)
Table 52. Global Coronary Drug-Coated Balloon Sales Market Share by Type (2019-2024)
Table 53. Global Coronary Drug-Coated Balloon Sales Market Share by Type (2025-2030)
Table 54. Global Coronary Drug-Coated Balloon Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Coronary Drug-Coated Balloon Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Coronary Drug-Coated Balloon Revenue Market Share by Type (2019-2024)
Table 57. Global Coronary Drug-Coated Balloon Revenue Market Share by Type (2025-2030)
Table 58. Global Coronary Drug-Coated Balloon Price (US$/Unit) by Type (2019-2024)
Table 59. Global Coronary Drug-Coated Balloon Price (US$/Unit) by Type (2025-2030)
Table 60. Global Coronary Drug-Coated Balloon Sales (K Units) by Application (2019-2024)
Table 61. Global Coronary Drug-Coated Balloon Sales (K Units) by Application (2025-2030)
Table 62. Global Coronary Drug-Coated Balloon Sales Market Share by Application (2019-2024)
Table 63. Global Coronary Drug-Coated Balloon Sales Market Share by Application (2025-2030)
Table 64. Global Coronary Drug-Coated Balloon Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Coronary Drug-Coated Balloon Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Coronary Drug-Coated Balloon Revenue Market Share by Application (2019-2024)
Table 67. Global Coronary Drug-Coated Balloon Revenue Market Share by Application (2025-2030)
Table 68. Global Coronary Drug-Coated Balloon Price (US$/Unit) by Application (2019-2024)
Table 69. Global Coronary Drug-Coated Balloon Price (US$/Unit) by Application (2025-2030)
Table 70. B. Braun Corporation Information
Table 71. B. Braun Description and Business Overview
Table 72. B. Braun Coronary Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. B. Braun Coronary Drug-Coated Balloon Product
Table 74. B. Braun Recent Developments/Updates
Table 75. Yinyi Corporation Information
Table 76. Yinyi Description and Business Overview
Table 77. Yinyi Coronary Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Yinyi Coronary Drug-Coated Balloon Product
Table 79. Yinyi Recent Developments/Updates
Table 80. Eurocor Corporation Information
Table 81. Eurocor Description and Business Overview
Table 82. Eurocor Coronary Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Eurocor Coronary Drug-Coated Balloon Product
Table 84. Eurocor Recent Developments/Updates
Table 85. Biotronic Corporation Information
Table 86. Biotronic Description and Business Overview
Table 87. Biotronic Coronary Drug-Coated Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Biotronic Coronary Drug-Coated Balloon Product
Table 89. Biotronic Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Coronary Drug-Coated Balloon Distributors List
Table 93. Coronary Drug-Coated Balloon Customers List
Table 94. Coronary Drug-Coated Balloon Market Trends
Table 95. Coronary Drug-Coated Balloon Market Drivers
Table 96. Coronary Drug-Coated Balloon Market Challenges
Table 97. Coronary Drug-Coated Balloon Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Coronary Drug-Coated Balloon
Figure 2. Global Coronary Drug-Coated Balloon Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Coronary Drug-Coated Balloon Market Share by Type in 2023 & 2030
Figure 4. Paclitaxel Coated Product Picture
Figure 5. Other Coated Product Picture
Figure 6. Global Coronary Drug-Coated Balloon Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Coronary Drug-Coated Balloon Market Share by Application in 2023 & 2030
Figure 8. Hospitals
Figure 9. ASCs
Figure 10. Catheterization Laboratory
Figure 11. Global Coronary Drug-Coated Balloon Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Coronary Drug-Coated Balloon Market Size (2019-2030) & (US$ Million)
Figure 13. Global Coronary Drug-Coated Balloon Sales (2019-2030) & (K Units)
Figure 14. Global Coronary Drug-Coated Balloon Average Price (US$/Unit) & (2019-2030)
Figure 15. Coronary Drug-Coated Balloon Report Years Considered
Figure 16. Coronary Drug-Coated Balloon Sales Share by Manufacturers in 2023
Figure 17. Global Coronary Drug-Coated Balloon Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Coronary Drug-Coated Balloon Players: Market Share by Revenue in 2023
Figure 19. Coronary Drug-Coated Balloon Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Coronary Drug-Coated Balloon Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Coronary Drug-Coated Balloon Sales Market Share by Country (2019-2030)
Figure 22. North America Coronary Drug-Coated Balloon Revenue Market Share by Country (2019-2030)
Figure 23. United States Coronary Drug-Coated Balloon Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Coronary Drug-Coated Balloon Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Coronary Drug-Coated Balloon Sales Market Share by Country (2019-2030)
Figure 26. Europe Coronary Drug-Coated Balloon Revenue Market Share by Country (2019-2030)
Figure 27. Germany Coronary Drug-Coated Balloon Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Coronary Drug-Coated Balloon Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Coronary Drug-Coated Balloon Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Coronary Drug-Coated Balloon Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Coronary Drug-Coated Balloon Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Coronary Drug-Coated Balloon Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Coronary Drug-Coated Balloon Revenue Market Share by Region (2019-2030)
Figure 34. China Coronary Drug-Coated Balloon Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Coronary Drug-Coated Balloon Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Coronary Drug-Coated Balloon Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Coronary Drug-Coated Balloon Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Coronary Drug-Coated Balloon Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Coronary Drug-Coated Balloon Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Coronary Drug-Coated Balloon Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Coronary Drug-Coated Balloon Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Coronary Drug-Coated Balloon Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Coronary Drug-Coated Balloon Sales Market Share by Country (2019-2030)
Figure 44. Latin America Coronary Drug-Coated Balloon Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Coronary Drug-Coated Balloon Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Coronary Drug-Coated Balloon Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Coronary Drug-Coated Balloon Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Coronary Drug-Coated Balloon Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Coronary Drug-Coated Balloon Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Coronary Drug-Coated Balloon Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Coronary Drug-Coated Balloon Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Coronary Drug-Coated Balloon Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Coronary Drug-Coated Balloon by Type (2019-2030)
Figure 54. Global Revenue Market Share of Coronary Drug-Coated Balloon by Type (2019-2030)
Figure 55. Global Coronary Drug-Coated Balloon Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Coronary Drug-Coated Balloon by Application (2019-2030)
Figure 57. Global Revenue Market Share of Coronary Drug-Coated Balloon by Application (2019-2030)
Figure 58. Global Coronary Drug-Coated Balloon Price (US$/Unit) by Application (2019-2030)
Figure 59. Coronary Drug-Coated Balloon Value Chain
Figure 60. Coronary Drug-Coated Balloon Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
